Brief: AIM ImmunoTech Says Director Nominations From Jorgl Activist Group Are Invalid
18/07/2022 13:40
July 18 (Reuters) - AIM ImmunoTech Inc AIM.A :
* AIM IMMUNOTECH ANNOUNCES THAT RECENTLY RECEIVED DIRECTOR
NOMINATIONS FROM JORGL ACTIVIST GROUP ARE INVALID
* AIM IMMUNOTECH INC - FILED A COMPLAINT IN U.S. DISTRICT
COURT
FOR MIDDLE DISTRICT OF FLORIDA, OCALA DIVISION, AGAINST JORGL
ACTIVIST GROUP
* AIM IMMUNOTECH INC - AIM BELIEVES ACTIVIST GROUP
INDIVIDUALS
HAVE FAILED TO REGISTER AS A GROUP PURSUANT TO U.S. SECURITIES
LAWS
* AIM IMMUNOTECH INC - STOCKHOLDERS DO NOT NEED TO TAKE ANY
ACTION
AT THIS TIME
* AIM IMMUNOTECH INC - AIM BOARD UNANIMOUSLY REJECTED
NOMINATION
NOTICE
Source text for Eikon: ID:nGNX6ZwZWW
Further company coverage: AIM.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AIM ImmunoTech
See all newsBrief: Aim Immunotech Duripanc Primary Endpoint Analysis To Begin December 2026 Topline Results Expected Q1 2027
Brief: Aim Immunotech Files To Offer And Resell Up To 13.08 Million Shares Of Common Stock By Selling Stockholders
Brief: AIM ImmunoTech Announces $2.65 Million Financing Priced At-Market Under NYSE American Rules
Brief: Aim Immunotech Announces Significant Increase In Stockholder Equity And Extension Of Promissory Note Maturity Date To June 2027
Brief: Aim Immunotech Announces 50% Objective Response Rate (Orr) In Upmc Recurrent Ovarian Cancer Phase 2 Clinical Trial, Suggesting Breakthrough Combination Potential